Transcranial Magnetic Stimulation in Depression

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018746
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
  Purpose

The study examines efficacy of repetitive transcranial magnetic stimulation in treating severely depressed patients who are medicated.


Condition Intervention Phase
Depression
Device: repetitive transcranial magnetic stimulation
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Study Start Date: July 1999
Estimated Study Completion Date: July 2001
Detailed Description:

Medicated, treatment resistant, depressed patients are randomized to active or sham repetitive transcranial magnetic stimulation (rTMS). Responding patients go into a six months follow-up period.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

severe treatment-resistant depression

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018746

Locations
United States, Connecticut
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
Investigators
Investigator: Ralph Hoffman
Investigator: Dan Oren
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00018746     History of Changes
Other Study ID Numbers: MHBS-037-98S
Study First Received: July 3, 2001
Last Updated: January 20, 2009
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014